Global Rapid Microbiology Testing Market – Industry Trends and Forecast to 2030

Rapid Microbiology Testing Market Analysis and Size

Increasing food safety concerns is the vital factor escalating the market growth, also increasing technological advancements, rising funding, research grants, and public-private investments, rising adoption of microbiology testing for the diagnosis of infectious diseases in humans, increasing emphasis on effective and early disease diagnosis, increase in the number of research activities, rise in the number of infection diseases and increase in the technological advancements are the major factors among others driving the rapid microbiology testing market. Moreover, increasing government initiatives for the detection of antimicrobial resistance, increasing emerging countries and rising bioterrorism surveillance will further create new opportunities for rapid microbiology testing market in the forecasted period. However, rising unfavourable reimbursement policies is the major factor among others which will obstruct the market growth, while increasing cost of rapid microbiology testing instruments will further challenge the growth of rapid microbiology testing market in the forecast period.             

Data Bridge Market Research analyses that the global rapid microbiology testing market, which was USD 4514.27 million in 2022, would rocket up to USD 9,597.19million by 2030, and is expected to undergo a CAGR of 9.4% during the forecast period. This indicates that the instrument segment dominates the product segment of the rapid microbiology testing market owing to the advancements in technology. In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research also include depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.

Rapid Microbiology Testing Market Scope and Segmentation

Market Definition

Microbiology is termed as the branch of medical science that deals with the treatment, diagnosis, and prevention of infectious diseases. Rapid microbiology testing method is also termed as microbiological methods and these are the type of technologies which are useful to get microbiology tests results faster as compared to traditional culture-plate methods.

Rapid Microbiology Testing Market Dynamics

Drivers

• Increasing Demand for Food Safety

The food and beverage industry has a growing need for rapid microbiology testing methods to ensure the safety and quality of products. Foodborne illnesses and product recalls have heightened awareness of the importance of microbiological testing in this sector

• Rising Technological Advancements

Advances in technology, such as automation, miniaturization, and the development of innovative detection methods (for instance, PCR, sequencing, biosensors), have made rapid microbiology testing more accessible, faster, and reliable

• Outbreak Management

Rapid microbiology testing plays a crucial role in managing and mitigating disease outbreaks, whether they are related to foodborne pathogens, nosocomial infections, or emerging infectious diseases

• Growing Awareness

Increased awareness of the importance of microbiological testing for public health and product safety has led to greater acceptance and adoption of rapid methods

Opportunities

• Expanded Applications

Rapid microbiology testing methods can find applications beyond their current use in industries such as food, pharmaceuticals, healthcare, and environmental monitoring. There is potential for growth in areas like cosmetics, personal care products, and agriculture.

• Point-of-care Testing

The development of portable and user-friendly rapid microbiology testing devices for point-of-care diagnostics offers significant growth potential. These devices can be used in clinics, doctor's offices, and even remote or resource-limited settings

Restraints/Challenges

• High Initial Costs

The upfront costs associated with acquiring and implementing rapid microbiology testing equipment and technologies can be substantial. This can deter smaller businesses and laboratories from adopting these methods

• imited Adoption in Traditional Settings

Traditional and well-established laboratories and testing facilities may be resistant to change, making it difficult for rapid methods to replace or complement existing, culture-based techniques.

This rapid microbiology testingnmarket report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the rapid microbiology testing market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth

Recent Developments

• In June 2022, STEMart, announced the launch of new microbiology testing and sterility testing specifically designed for sterile, non-pyrogenic products
• In July 2020, Neogen Corporation (NASDAQ: NEOG) announced that it has launched an advanced test system that automatically detects microorganisms in a fraction of the time of traditional testing methods

Global Rapid Microbiology Testing Market Scope

The rapid microbiology testing market is segmented on the basis of product, application, method and end-user. The growth amongst these segments will help you analyse meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

By Product

• Instruments
• Reagents and kits
• Consumables

Application

• Clinical Disease Diagnosis
• Food and Beverage Testing
• Pharmaceutical and Biological Drug Testing
• Environmental Testing
• Cosmetics and Personal Care Products Testing
• Research Applications
• Other Applications

Method

• Growth-Based Rapid Microbiology Testing
• Cellular Component-Based Rapid Microbiology Testing
• Nucleic Acid-Based Rapid Microbiology Testing
• Viability-Based Rapid Microbiology Diagnostic Testing
• Other Rapid Microbiology Testing Methods

End-User

• Laboratories and  Hospitals
• Food and  Beverage Companies
• Pharmaceutical and  Biotechnology Companies
• Contract Research Organizations
• Other End-Users

Rapid Microbiology Testing Market Regional Analysis/Insights

The rapid microbiology testing market is analysed and market size insights and trends are provided by product, application, method and end-user, as referenced above.

The countries covered in the rapid microbiology testing market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E., South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America

North America dominates the rapid microbiology testing market because of the strong base of healthcare facilities, strong presence of major players in the market, rising demand of the rapid microbiology testing products and rising number of research activities in this region.   

Asia-Pacific is expected to witness significant growth during the forecast period of 2023 to 2030 due to the increase in government initiatives to promote awareness, rise in medical tourism, growing research activities in the region, availability of massive untapped markets, large population pool, and the growing demand for quality healthcare in the region.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as down-stream and up-stream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.   

Healthcare Infrastructure Growth Installed Base and New Technology Penetration

The rapid microbiology testing market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for Rapid Microbiology Testing market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the rapid microbiology testing market. The data is available for historic period 2010 to 2020.

Competitive Landscape and Rapid Microbiology Testing Market Share Analysis

The rapid microbiology testing market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to rapid microbiology testing market.

Some of the major players operating in the rapid microbiology testing market are:

• Abbott.(U.S.)
• BD (U.S.)
• BioMerieux SA (France)
• Bruker (U.S.)
• Charles River(U.S.)
• Danaher (U.S.)
• Don Whitley Scientific Limited (U.S.)
• Merck KGaA (U.S.)
• Neogen Corporation (U.S.)
•  Quidel Corporation (U.S.)
•  Rapid Micro Biosystems, Inc. (U.S.)
•  Sartorius Group (Germany)
•  Thermo Fisher Scientific (U.S.)
•  TSI (U.S.)
•  Vivione Biosciences Inc. (U.S.)
•  ERBA Diagnostics (U.S.)
• Vedalab (India)
•  Rtalabs (London)
• Shimadzu Corporation.(Japan)
•  Pall Corporation. (U.S.)
• Mocon, Inc (U.S.)

SKU-30558